Refereed journal article or data article (A1)

Epidemiology of ILDs and their progressive-fibrosing behaviour in six European countries




List of Authors: Hilberg Ole, Hoffmann-Vold Anna-Maria, Smith Vanessa, Bouros Demosthenes, Kilpeläinen Maritta, Guiot Julien, Morais Antonio, Clemente Susana, Daniil Zoe, Papakosta Despina, Fretheim Havard, Neves Sofia, Alfaro Tiago M., Antoniou Katerina M., Valveny Neus, Asijee Guus, Soulard Stephane, Wuyts Wim; on behalf of PERSEIDS study group

Publisher: European Respiratory Society

Publication year: 2021

Journal: ERJ Open Research

Volume number: 8

Issue number: 1

eISSN: 2312-0541

DOI: http://dx.doi.org/10.1183/23120541.00597-2021

URL: https://openres.ersjournals.com/content/early/2021/11/11/23120541.00597-2021

Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/68673195


Abstract

The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs), fibrosing Interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated ILD (SSc-ILD), other non-IPF F-ILDs and their progressive-fibrosing (PF) forms in six European countries, as current data are scarce.

This retrospective, two-phase study used aggregate data (2014–2018). In Phase 1, incident/prevalent cases of ILDs above were identified from clinical databases through an algorithm based on codes/keywords, and incidence/prevalence was estimated. For non-IPF F–ILDs, the relative percentage of subtypes was also determined. In Phase 2, a subset of non-IPF F-ILD cases was manually reviewed to determine the percentage of PF behaviour and usual interstitial pneumonia-like (UIP-like) pattern. A weighted mean percentage of progression was calculated for each country and used to extrapolate incidence/prevalence of progressive-fibrosing ILDs (PF–ILDs).

In 2018, incidence/105 person-years ranged between 9.4–83.6(ILDs), 7.7–76.2(F-ILDs), 0.4–10.3(IPF), 6.6–71.7(non-IPF F-ILDs) and 0.3–1.5(SSc-ILD); and prevalence/105 persons ranged between 33.6–247.4(ILDs), 26.7–236.8(F-ILDs), 2.8–31.0(IPF), 22.3–205.8(non-IPF F-ILDs) and 1.4–10.1(SSc-ILD). Among non-IPF F-ILDs, sarcoidosis was the most frequent subtype. PF behaviour and UIP-like pattern were present in a third of non-IPF F-ILD cases each and hypersensitivity pneumonitis showed the highest percentage of progressive behaviour. Incidence of PF-ILDs ranged between 2.1–14.5/105 person-years, and prevalence between 6.9–78.0/105 persons.

To our knowledge, PERSEIDS is the first study assessing incidence, prevalence and rate of progression of ILDs across several European countries. Still below the threshold for orphan diseases, the estimates obtained were higher and more variable than reported in previous studies, but differences in study design/population must be considered.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Last updated on 2022-07-04 at 16:21